Semaglutide
Semaglutide
Semaglutide (pronounced: seh-muh-gloo-tide) is a medication used for the treatment of Type 2 diabetes and obesity. It is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that is administered via injection.
Etymology
The name "Semaglutide" is derived from the words "semi", meaning half, and "glutide", which is a reference to its function as a glucagon-like peptide-1 receptor agonist.
Usage
Semaglutide is used to improve blood sugar control in adults with type 2 diabetes. It is often used when diet and exercise alone does not control blood sugar. Semaglutide is also used for weight management in adults who are overweight or have obesity.
Mechanism of Action
Semaglutide works by mimicking the function of a hormone in the body called glucagon-like peptide-1 (GLP-1). This hormone is released into the bloodstream after a meal and helps to regulate blood sugar levels. Semaglutide binds to the GLP-1 receptors in the pancreas, stimulating the release of insulin, which lowers blood sugar levels.
Side Effects
Common side effects of Semaglutide include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. More serious side effects can include pancreatitis, changes in vision, and kidney problems.
Related Terms
External links
- Medical encyclopedia article on Semaglutide
- Wikipedia's article - Semaglutide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski